Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance

Molecular and Cellular Endocrinology

Volumn 378, Issue 1-2, 2013, Pages 1-14

  Marcus, Yonit ^a   Shefer, Gabi ^a,b   Stern, Naftali ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adipocytes; Hypertension; Inflammation; Obesity; Type 2 diabetes; Visceral fat

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; CYCLIC AMP; FATTY ACID; MESSENGER RNA; RENIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALDOSTERONE RELEASE; CELL DIFFERENTIATION; CELL VOLUME; FAT MASS; FIBROSIS; GENE EXPRESSION; HUMAN; HYPEROXIA; HYPOXIA; INSULIN RESISTANCE; INSULIN RESPONSE; LIPID STORAGE; LIPOLYSIS; NONHUMAN; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ADIPOCYTES; HYPERTENSION; INFLAMMATION; OBESITY; TYPE 2 DIABETES; VISCERAL FAT;

ADIPOSE TISSUE; ANIMALS; HUMANS; INSULIN RESISTANCE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84884417606     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.021     Document Type: Review

References (187)

1. Abadir P.M. The frail renin-angiotensin system. Clin. Geriatr. Med. 2011, 27:53-66.
2. Achard V., Boullu-Ciocca S., Desbriere R., Nguyen G., Grino M. Renin receptor expression in human adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R274-282.
3. Achard V., Tassistro V., Boullu-Ciocca S., Grino M. Expression and nutritional regulation of the (pro)renin receptor in rat visceral adipose tissue. J. Endocrinol. Invest. 2011, 34:840-846.
4. Adams F., Wiedmer P., Gorzelniak K., Engeli S., Klaus S., Boschmann M. Age-related changes of renin-angiotensin system genes in white adipose tissue of rats. Horm. Metab. Res. 2002, 34:716-720.
5. Aguilar F., Lo M., Claustrat B., Saez J.M., Sassard J., Li J.Y. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension 2004, 43:87-93.
6. Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000, 11:327-332.
7. Alligier M., Meugnier E., Debard C., Lambert-Porcheron S., Chanseaume E., Sothier M., Loizon E., Hssain A.A., Brozek J., Scoazec J.Y., et al. Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J. Clin. Endocrinol. Metab. 2012, 97:E183-192.
8. Araki K., Masaki T., Katsuragi I., Tanaka K., Kakuma T., Yoshimatsu H. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 2006, 48:51-57.
9. Arner P., Hellstrom L., Wahrenberg H., Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. J. Clin. Invest. 1990, 86:1595-1600.
10. Arner P., Lithell H., Wahrenberg H., Bronnegard M. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. J. Lipid Res. 1991, 32:423-429.
11. Aubert J., Darimont C., Safonova I., Ailhaud G., Negrel R. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem. J. 1997, 328:701-706.
12. Aubert J., Safonova I., Negrel R., Ailhaud G. Insulin down-regulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells. Biochem. Biophys. Res. Commun. 1998, 250:77-82.
13. Azekoshi Y., Yasu T., Watanabe S., Tagawa T., Abe S., Yamakawa K., Uehara Y., Momomura S., Urata H., Ueda S. Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 2010, 56:136-U218.
14. Bays H., Rodbard H.W., Schorr A.B., Gonzalez-Campoy J.M. Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk. Curr. Treat. Options Cardiovasc. Med. 2007, 9:259-271.
15. Benson S.C., Pershadsingh H.A., Ho C.I., Chittiboyina A., Desai P., Pravenec M., Qi N.N., Wang J.M., Avery M.A., Kurtz T.W. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity. Hypertension 2004, 43:993-1002.
16. Bergman R.N., Mittelman S.D. Central role of the adipocyte in insulin resistance. J. Basic Clin. Physiol. Pharmacol. 1998, 9:205-221.
17. Boney C.M., Sekimoto H., Gruppuso P.A., Frackelton A.R. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. Cell Growth Differ. 2001, 12:379-386.
18. Boschmann M., Ringel J., Klaus S., Sharma A.M. Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes. Res. 2001, 9:486-491.
19. Boustany C.M., Bharadwaj K., Daugherty A., Brown D.R., Randall D.C., Cassis L.A. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R943-949.
20. Brucher R., Cifuentes M., Acuna M.J., Albala C., Rojas C.V. Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans. Obesity (Silver Spring) 2007, 15:1643-1646.
21. Caprio M., Antelmi A., Chetrite G., Muscat A., Mammi C., Marzolla V., Fabbri A., Zennaro M.C., Feve B. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology 2011, 152:113-125.
22. Caprio M., Feve B., Claes A., Viengchareun S., Lombes M., Zennaro M.C. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J. 2007, 21:2185-2194.
23. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr. Rev. 2003, 24:261-271.
24. Carranza M.C., Torres A., Calle C. Decreased insulin receptor number and affinity in subcutaneous adipose tissue in a patient with primary hyperaldosteronism. Rev. Clin. Esp. 1991, 188:414-417.
25. Cassis L.A. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am. J. Physiol. 1992, 262:E105-109.
26. Cassis L.A. Angiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats. Am. J. Physiol. 1994, 266:E453-458.
27. Cassis L.A., English V.L., Bharadwaj K., Boustany C.M. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 2004, 145:169-174.
28. Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system. Curr. Hypertens. Rep. 2008, 10:93-98.
29. Cassis L.A., Saye J., Peach M.J. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988, 11:591-596.
30. Cassis P., Conti S., Remuzzi G., Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch.-European J. Physiol. 2010, 459:325-332.
31. Chen Y., Naftilan A., Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992, 19:456-463.
32. Clasen R., Schupp M., Foryst-Ludwig A., Sprang C., Clemenz M., Krikov M., Thone-Reineke C., Unger T., Kintscher U. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 2005, 46:137-143.
33. Cooper S.A., Whaley-Connell A., Habibi J., Wei Y., Lastra G., Manrique C., Stas S., Sowers J.R. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2009-2023.
34. Crandall D.L., Armellino D.C., Busler D.E., McHendry-Rinde B., Kral J.G. Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 1999, 140:154-158.
35. Crandall D.L., Herzlinger H.E., Saunders B.D., Armellino D.C., Kral J.G. Distribution of angiotensin-Ii receptors in rat and human adipocytes. J. Lipid Res. 1994, 35:1378-1385.
36. Csibi A., Communi D., Müller N & Bottari S.P. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS ONE 2010, 5:e10070.
37. Dall'Asta C., Vedani P., Manunta P., Pizzocri P., Marchi M., Paganelli M., Folli F., Pontiroli A.E. Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr. Metab. Cardiovasc. Dis. 2009, 19:110-114.
38. Darimont C., Vassaux G., Ailhaud G., Negrel R. Differentiation of preadipose cells - paracrine role of prostacyclin upon stimulation of adipose-cells by angiotensin-Ii. Endocrinology 1994, 135:2030-2036.
39. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 2000, 105:1605-1612.
40. de Kloet A.D., Krause E.G., Kim D.H., Sakai R.R., Seeley R.J., Woods S.C. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 2009, 150:4114-4123.
41. de Kloet A.D., Krause E.G., Scott K.A., Foster M.T., Herman J.P., Sakai R.R., Seeley R.J., Woods S.C. Central angiotensin II has catabolic action at white and brown adipose tissue. Am. J. Physiolo. Endocrinol. Metab. 2011, 301:E1081-E1091.
42. de Kloet A.D., Krause E.G., Woods S.C. The renin-angiotensin system and the metabolic syndrome. Physiol. Behav. 2010, 100:525-534.
43. Deshaies Y., Geloen A., Paulin A., Marette A., Bukowiecki L.J. Tissue-specific alterations in lipoprotein lipase activity in the rat after chronic infusion of isoproterenol. Horm. Metab. Res. 1993, 25:13-16.
44. Dowling H.J., Fried S.K., Pi-Sunyer F.X. Insulin resistance in adipocytes of obese women: effects of body fat distribution and race. Metab. Clin. Exp. 1995, 44:987-995.
45. Ehrhart-Bornstein M., Arakelyan K., Krug A.W., Scherbaum W.A., Bornstein S.R. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr. Res. 2004, 30:865-870.
46. Engeli S., Bohnke J., Gorzelniak K., Janke J., Schling P., Bader M., Luft F.C., Sharma A.M. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45:356-362.
47. Engeli S., Boschmann M., Frings P., Beck L., Janke J., Titze J., Luft F.C., Heer M., Jordan J. Influence of salt intake on renin-angiotensin and natriuretic peptide system genes in human adipose tissue. Hypertension 2006, 48:1103-1108.
48. English V., Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J. Neural Transm. 1999, 106:631-644.
49. Fallo F., Veglio F., Bertello C., Sonino N., Della Mea P., Ermani M., Rabbia F., Federspil G., Mulatero P. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J. Clin. Endocrinol. Metab. 2006, 91:454-459.
50. Faloia E., Gatti C., Camilloni M.A., Mariniello B., Sardu C., Garrapa G.G., Mantero F., Giacchetti G. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J. Endocrinol. Invest. 2002, 25:309-314.
51. Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005, 111:2605-2610.
52. Fowler J.D., Johnson N.D., Haroldson T.A., Brintnall J.A., Herrera J.E., Katz S.A., Bernlohr D.A. Regulated renin release from 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1383-1391.
53. Fowler J.D., Krueth S.B., Bernlohr D.A., Katz S.A. Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E343-350.
54. Frederich R.C., Kahn B.B., Peach M.J., Flier J.S. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339-344.
55. Fuentes P., Acuna M.J., Cifuentes M., Rojas C.V. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J. Endocrinol. 2010, 206:75-83.
56. Fujisaka S., Usui I., Kanatani Y., Ikutani M., Takasaki I., Tsuneyama K., Tabuchi Y., Bukhari A., Yamazaki Y., Suzuki H., et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology 2011, 152:1789-1799.
57. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., Yoshida D., Shimamoto K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42:76-81.
58. Furuhashi M., Ura N., Takizawa H., Yoshida D., Moniwa N., Murakami H., Higashiura K., Shimamoto K. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J. Hypertens. 2004, 22:1977-1982.
59. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
60. Gembardt F., Sterner-Kock A., Imboden H., Spalteholz M., Reibitz F., Schultheiss H.P., Siems W.E., Walther T. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 2005, 26:1270-1277.
61. Giacchetti G., Faloia E., Mariniello B., Sardu C., Gatti C., Camilloni M.A., Guerrieri M., Mantero F. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am. J. Hypertens. 2002, 15:381-388.
62. Giacchetti G., Ronconi V., Turchi F., Agostinelli L., Mantero F., Rilli S., Boscaro M. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J. Hypertens. 2007, 25:177-186.
63. Goodfriend T.L., Ball D.L., Egan B.M., Campbell W.B., Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004, 43:358-363.
64. Goodfriend T.L., Kelley D.E., Goodpaster B.H., Winters S.J. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes. Res. 1999, 7:355-362.
65. Goossens G.H., Bizzarri A., Venteclef N., Essers Y., Cleutjens J.P., Konings E., Jocken J.W.E., Cajlakovic M., Ribitsch V., Clement K., et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 2011, 124:67-76.
66. Goossens G.H., Blaak E.E., Arner P., Saris W.H.M., Van Baak M.A. Angiotensin II: a hormone that affects lipid metabolism in adipose tissue. Int. J. Obes. 2007, 31:382-384.
67. Goossens G.H., Jocken J.W., Blaak E.E., Schiffers P.M., Saris W.H., van Baak M.A. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 2007, 49:542-547.
68. Goossens G.H., McQuaid S.E., Dennis A.L., van Baak M.A., Blaak E.E., Frayn K.N., Saris W.H., Karpe F. Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans. J. Physiol. 2006, 571:451-460.
69. Guo C., Ricchiuti V., Lian B.Q., Yao T.M., Coutinho P., Romero J.R., Li J., Williams G.H., Adler G.K. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008, 117:2253-2261.
70. Gupte M., Boustany-Kari C.M., Bharadwaj K., Police S., Thatcher S., Gong M.C., English V.L., Cassis L.A. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R781-R788.
71. Hainault I., Nebout G., Turban S., Ardouin B., Ferre P., Quignard-Boulange A. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E59-66.
72. Hamdy O., Porramatikul S., Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr. Diabetes Rev. 2006, 2:367-373.
73. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 2003, 91:7A-11A.
74. Harte A.L., McTernan P.G., McTernan C.L., Crocker J., Starcynski J., Barnett A.H., Matyka K., Kumar S. Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes. Diabetes Obes. Metab. 2003, 5:462-467.
75. Hayden M.R., Sowers K.M., Pulakat L., Joginpally T., Krueger B., Whaley-Connell A., Sowers J.R. Possible mechanisms of local tissue renin-angiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus. Cardiorenal Med. 2011, 1:193-210.
76. He Q., Gao Z.G., Yin J., Zhang J., Yun Z., Ye J.P. Regulation of HIF-1 alpha activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E877-E885.
77. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., Poitou C., Basdevant A., Stich V., Viguerie N., et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008, 9:R14.
78. Hosain G.M.M., Rahman M., Williams K.J., Berenson A.B. Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women. Diabetes Metab. 2010, 36:278-285.
79. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
80. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
81. Iacobellis G., Petramala L., Cotesta D., Pergolini M., Zinnamosca L., Cianci R., De Toma G., Sciomer S., Letizia C. Adipokines and cardiometabolic profile in primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 2010, 95:2391-2398.
82. Iwai M., Horiuchi M. Role of renin-angiotensin system in adipose tissue dysfunction. Hypertens. Res. 2009, 32:425-427.
83. Iwai M., Tomono Y., Inaba S., Kanno H., Senba I., Mogi M., Horiuchi M. AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am. J. Hypertens. 2009, 22:784-791.
84. Jain S., Li Y., Patil S., Kumar A. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J. Mol. Med. Jmm 2005, 83:121-131.
85. Jandeleit-Dahm K.A., Tikellis C., Reid C.M., Johnston C.I., Cooper M.E. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J. Hypertens. 2005, 23:463-473.
86. Janke J., Engeli S., Gorzelniak K., Luft F.C., Sharma A.M. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002, 51:1699-1707.
87. Jayasooriya A.P., Mathai M.L., Walker L.L., Begg D.P., Denton D.A., Cameron-Smith D., Egan G.F., McKinley M.J., Rodger P.D., Sinclair A.J., et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc. Nat. Acad. Sci. USA 2008, 105:6531-6536.
88. Jones B.H., Standridge M.K., Taylor J.W., Moustaid N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physiol. 1997, 273:R236-242.
89. Jonsson J.R., Game P.A., Head R.J., Frewin D.B. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press. 1994, 3:72-75.
90. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
91. Kalupahana N.S., Massiera F., Quignard-Boulange A., Ailhaud G., Voy B.H., Wasserman D.H., Moustaid-Moussa N. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring) 2012, 20:48-56.
92. Karlsson C., Lindell K., Ottosson M., Sjostrom L., Carlsson B., Carlsson L.M. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J. Clin. Endocrinol. Metab. 1998, 83:3925-3929.
93. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., Zhang B.B., Bonaldo P., Chua S., Scherer P.E. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 2009, 29:1575-1591.
94. Kim S., Soltani-Bejnood M., Quignard-Boulange A., Massiera F., Teboul M., Ailhaud G., Kim J.H., Moustaid-Moussa N., Voy B.H. The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J. Biomed. Biotechnol. 2006, 27012.
95. Kouyama R., Suganami T., Nishida J., Tanaka M., Toyoda T., Kiso M., Chiwata T., Miyamoto Y., Yoshimasa Y., Fukamizu A., et al. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 2005, 146:3481-3489.
96. Krskova K., Filipcik P., Zilka N., Olszanecki R., Korbut R., Gajdosechova L., Zorad S. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARgamma). J. Physiol. Pharmacol. 2011, 62:403-410.
97. Krug A.W., Vleugels K., Schinner S., Lamounier-Zepter V., Ziegler C.G., Bornstein S.R., Ehrhart-Bornstein M. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells. Int. J. Obes. (Lond.) 2007, 31:1605-1616.
98. Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., Okada T., Ohashi K., Hibuse T., Fujita K., Yasui A., et al. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int. 2006, 70:1717-1724.
99. Lambert D.W., Yarski M., Warner F.J., Thornhill P., Parkin E.T., Smith A.I., Hooper N.M., Turner A.J. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 2005, 280:30113-30119.
100. Lamounier-Zepter V., Ehrhart-Bornstein M. Fat tissue metabolism and adrenal steroid secretion. Curr. Hypertens. Rep. 2006, 8:30-34.
101. Lastra G., Whaley-Connell A., Manrique C., Habibi J., Gutweiler A.A., Appesh L., Hayden M.R., Wei Y., Ferrario C., Sowers J.R. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E110-116.
102. Lee M.H., Song H.K., Ko G.J., Kang Y.S., Han S.Y., Han K.H., Kim H.K., Han J.Y., Cha D.R. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int. 2008, 74:890-900.
103. Lee R.M., Ding L., Lu C., Su L.Y., Gao Y.J. Alteration of perivascular adipose tissue function in angiotensin II-induced hypertension. Can. J. Physiol. Pharmacol. 2009, 87:944-953.
104. Limor, R., Moataz, U., Knoll, E. and Stern, N., 2012. Aldosterone increases oxidative stress in differentiated but not in undifferentiated 3T3-L1 adipocytes via activation of mineralocorticoid and glucocorticoid receptors. In International Congress of Endocrinology, p Abstract. Florence.
105. Liu C., Lv X.H., Li H.X., Cao X., Zhang F., Wang L., Yu M., Yang J.K. Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 2011.
106. Lonnroth P., Smith U. Intermediary metabolism with an emphasis on lipid metabolism, adipose tissue, and fat cell metabolism: a review. Obesity 1992, Lippincott, Philadelphia, pp 3-14. P. Bjorntorp, B.N. Brodoff (Eds.).
107. Lu C., Su L.Y., Lee R.M., Gao Y.J. Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur. J. Pharmacol. 2010, 634:107-112.
108. Lu H., Boustany-Kari C.M., Daugherty A., Cassis L.A. Angiotensin II increases adipose angiotensinogen expression. Am. J. Physiol. - Endocrinol. Metab. 2007, 292:E1280-E1287.
109. Ma L.J., Corsa B.A., Zhou J., Yang H., Li H., Tang Y.W., Babaev V.R., Major A.S., Linton M.F., Fazio S., et al. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Am. J. Physiol. Renal. Physiol. 2011, 300:F1203-1213.
110. Mallow H., Trindl A., Loffler G. Production of angiotensin II receptors type one (AT1) and type two (AT2) during the differentiation of 3T3-L1 preadipocytes. Horm. Metab. Res. 2000, 32:500-503.
111. Marzolla V., Armani A., Zennaro M.C., Cinti F., Mammi C., Fabbri A., Rosano G.M., Caprio M. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol. 2012, 350:281-288.
112. Massiera, F., Bloch-Faure, M., Ceiler, D., Murakami, K., Fukamizu, A., Gasc, J.M., Quignard-Boulange, A., Negrel, R., Ailhaud, G., Seydoux, J., et al. 2001a. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB Journal 15 2727-+.
113. Massiera F., Seydoux J., Geloen A., Quignard-Boulange A., Turban S., Saint-Marc P., Fukamizu A., Negrel R., Ailhaud G., Teboul M. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 2001, 142:5220-5225.
114. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
115. Masuzaki H., Yamamoto H., Kenyon C.J., Elmquist J.K., Morton N.M., Paterson J.M., Shinyama H., Sharp M.G.F., Fleming S., Mullins J.J., et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Investig. 2003, 112:83-90.
116. Mathai M.L., Naik S., Sinclair A.J., Weisinger H.S., Weisinger R.S. Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int. J. Obes. (Lond.) 2008, 32:1576-1584.
117. Matrozova J., Steichen O., Amar L., Zacharieva S., Jeunemaitre X., Plouin P.F. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 2009, 53:605-610.
118. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 1998, 83:1182-1191.
119. McGehee R.E., Ron D., Brasier A.R., Habener J.F. Differentiation-specific element: a cis-acting developmental switch required for the sustained transcriptional expression of the angiotensinogen gene during hormonal-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Mol. Endocrinol. 1993, 7:551-560.
120. Moan A., Eide I.K., Kjeldsen S.E. Metabolic and adrenergic characteristics of young men with insulin resistance. Blood Press. Suppl. 1996, 1:30-37.
121. Munoz M.C., Giani J.F., Dominici F.P., Turyn D., Toblli J.E. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese Zucker rats. J. Hypertens. 2009, 27:2409-2420.
122. Nagase M., Yoshida S., Shibata S., Nagase T., Gotoda T., Ando K., Fujita T. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J. Am. Soc. Nephrol. 2006, 17:3438-3446.
123. Nguyen G. Renin and prorenin receptor in hypertension: what's new?. Curr. Hypertens. Rep. 2011, 13:79-85.
124. Ogihara T., Asano T., Ando K., Chiba Y., Sakoda H., Anai M., Shojima N., Ono H., Onishi Y., Fujishiro M., et al. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 2002, 40:872-879.
125. Ozbey N., Sencer E., Molvalilar S., Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr. J. 2002, 49:503-509.
126. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., Jenkins A.B., Storlien L.H. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46:983-988.
127. Pasarica M., Gowronska-Kozak B., Burk D., Remedios I., Hymel D., Gimble J., Ravussin E., Bray G.A., Smith S.R. Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 2009, 94:5155-5162.
128. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., Rood J.C., Burk D.H., Smith S.R. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
129. Police S.B., Thatcher S.E., Charnigo R., Daugherty A., Cassis L.A. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29. 1458- U1123.
130. Pouliot M.C., Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., Bouchard C. Regional variation in adipose tissue lipoprotein lipase activity: association with plasma high density lipoprotein levels. Eur. J. Clin. Invest. 1991, 21:398-405.
131. Rahmouni K., Mark A.L., Haynes W.G., Sigmund C.D. Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E891-E895.
132. Rask E., Walker B.R., Soderberg S., Livingstone D.E., Eliasson M., Johnson O., Andrew R., Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J. Clin. Endocrinol. Metab. 2002, 87:3330-3336.
133. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int. J. Obes. 2008, 32:451-463.
134. Rondinone C.M., Rodbard D., Baker M.E. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993, 132:2421-2426.
135. Rosen E.D. The transcriptional basis of adipocyte development. Prostaglandins Leukot. Essent Fatty Acids 2005, 73:31-34.
136. Safonova I., Aubert J., Negrel R., Ailhaud G. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem. J. 1997, 322(Pt 1):235-239.
137. Saiki A., Koide N., Watanabe F., Murano T., Miyashita Y., Shirai K. Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system. Metab. Clin. Exp. 2008, 57:1093-1100.
138. Saiki A., Ohira M., Endo K., Koide N., Oyama T., Murano T., Miyashita Y., Shirai K. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension. Diabetes Res. Clin. Pract. 2006, 74:242-248.
139. Santos R.A.S., e Silva A.C.S., Maric C., Silva D.M.R., Machado R.P., de Buhr I., Heringer-Walther S., Pinheiro S.V.B., Lopes M.T., Bader M., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Nat. Acad. Sci. 2003, 100:8258-8263.
140. Santos S.H., Fernandes L.R., Mario E.G., Ferreira A.V., Porto L.C., Alvarez-Leite J.I., Botion L.M., Bader M., Alenina N., Santos R.A. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008, 57:340-347.
141. Saranteas T., Lolis E., Mourouzis C., Potamianou A., Tesseromatis C., Varonos D. Effect of Losartan on Insulin Plasma Concentrations and LPL Activity in Adipose Tissue of Hypertensive Rats. Horm. Metab. Res. 2003, 35(164):168.
142. Sarzani R., Marcucci P., Salvi F., Bordicchia M., Espinosa E., Mucci L., Lorenzetti B., Minardi D., Muzzonigro G., Dessi-Fulgheri P., et al. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int. J. Obes. (Lond.) 2008, 32:259-267.
143. Sarzani R., Salvi F., Dessi-Fulgheri P., Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J. Hypertens. 2008, 26:831-843.
144. Saye J.A., Cassis L.A., Sturgill T.W., Lynch K.R., Peach M.J. Angiotensinogen gene expression in 3T3-L1 cells. Am. J. Physiol. Cell Physiol. 1989, 256:C448-C451.
145. Sbarbati A., Osculati F., Silvagni D., Benati D., Galie M., Camoglio F.S., Rigotti G., Maffeis C. Obesity and inflammation: evidence for an elementary lesion. Pediatrics 2006, 117:220-223.
146. Seidell J.C., Perusse L., Despres J.P., Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am. J. Clin. Nutr. 2001, 74:315-321.
147. Serazin-Leroy V., Morot M., de Mazancourt P., Giudicelli Y. Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes. Am. J. Physiol. - Endocrinol. Metab. 2000, 279:E1398-E1405.
148. Serazin V., Dieudonné M.-N., Morot M., de Mazancourt P., Giudicelli Y. CAMP-positive regulation of angiotensinogen gene expression and protein secretion in rat adipose tissue. Am. J. Physiol. - Endocrinol. Metab. 2004, 286:E434-E438.
149. Sharma A.M., Janke J., Gorzelniak K., Engeli S., Luft F.C. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002, 40:609-611.
150. Shimabukuro M., Tanaka H., Shimabukuro T. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J. Hypertens. 2007, 25:841-848.
151. Shiuchi T., Iwai M., Li H.S., Wu L., Min L.J., Li J.M., Okumura M., Cui T.X., Horiuchi M. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 2004, 43:1003-1010.
152. Soltis E.E., Cassis L.A. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin. Exp. Hypertens. Part A, Theory and Pract. 1991, 13:277-296.
153. Stern N., Osher E., Greenman Y. Hypoadiponectinemia as a marker of adipocyte dysfunction-Part II: The functional significance of low adiponectin secretion. J. Cardiometab. Syndr. 2007, 2:288-294.
154. Stucchi P., Cano V., Ruiz-Gayo M., Fernandez-Alfonso M.S. Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br. J. Pharmacol. 2009, 158:771-778.
155. Sui Y., Zhao H.L., Fan R.R., Guan J., He L., Lee H.M., Chan J.C., Tong P.C. Renin-angiotensin system activation in renal adipogenesis. Am. J. Physiol. Renal Physiol. 2010, 298:F391-400.
156. Szasz T., Webb R.C. Perivascular adipose tissue: more than just structural support. Clin. Sci. 2012, 122:1-12.
157. Takahashi N., Li F., Hua K., Deng J., Wang C.H., Bowers R.R., Bartness T.J., Kim H.S., Harp J.B. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 2007, 6:506-512.
158. Takemori K., Gao Y.J., Ding L., Lu C., Su L.Y., An W.S., Vinson C., Lee R.M. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007, 49:365-372.
159. Tam C., Tordjman J., Divoux A., Baur L.A., Clement K. Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth. Obesity 2011, 19:S79.
160. Tanaka A., Nomura Y., Matsuda A., Ohmori K., Matsuda H. Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J(2). Am. J. Physiol. Cell Physiol. 2011, 301:C1360-C1367.
161. Thatcher S., Yiannikouris F., Gupte M., Cassis L. The adipose renin-angiotensin system: role in cardiovascular disease. Mol. Cell. Endocrinol. 2009, 302:111-117.
162. Tocci G., Paneni F., Palano F., Sciarretta S., Ferrucci A., Kurtz T., Mancia G., Volpe M. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. Am. J. Hypertens. 2011, 24:582-590.
163. Tomono Y., Iwai M., Inaba S., Mogi M., Horiuchi M. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models. Am. J. Hypertens. 2008, 21:206-212.
164. Tondu A.L., Robichon C., Yvan-Charvet L., Donne N., Le Liepvre X., Hajduch E., Ferre P., Dugail I., Dagher G. Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes. J. Biol. Chem. 2005, 280:33536-33540.
165. Townsend R.R. Angiotensin and insulin resistance. Conspiracy theory. Curr. Hypertens. Rep. 2003, 5:110-116.
166. Tsuchiya K., Yoshimoto T., Hirono Y., Tateno T., Sugiyama T., Hirata Y. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappa B-dependent pathway in rat preadipocytes. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E771-E778.
167. Tuck M.L., Sowers J., Dornfeld L., Kledzik G., Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N. Engl. J. Med. 1981, 304:930-933.
168. Turban S., Hainault I., Andre J., Ferre P., Quignard-Boulange A., Guerre-Millo M. Molecular and cellular mechanisms of adipose secretion: comparison of leptin and angiotensinogen. J. Cell. Biochem. 2001, 82:666-673.
169. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 1956, 4:20-34.
170. van Harmelen V., Ariapart P., Hoffstedt J., Lundkvist I., Bringman S., Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes. Res. 2000, 8:337-341.
171. Wahrenberg H., Lonnqvist F., Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J. Clin. Invest. 1989, 84:458-467.
172. Wang B., Jenkins J.R., Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α. American Journal of Physiology - Endocrinology And Metabolism 2005, 288:E731-E740.
173. Weiland F., Verspohl E.J. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Horm. Metab. Res. 2008, 40:760-766.
174. Williams M.J., Hunter G.R., Kekes-Szabo T., Snyder S., Treuth M.S. Regional fat distribution in women and risk of cardiovascular disease. Am. J. Clin. Nutr. 1997, 65:855-860.
175. Xing Y., Rainey W.E., Apolzan J.W., Francone O.L., Harris R.B.S., Bollag W.B. Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL). Endocrinology 2012, 153:721-731.
176. Yasue S., Masuzaki H., Okada S., Ishii T., Kozuka C., Tanaka T., Fujikura J., Ebihara K., Hosoda K., Katsurada A., et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice. Impact of nutritional status and adipocyte hypertrophy. Am. J. Hypertens. 2010, 23:425-431.
177. Ye J.P., Gao Z.G., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. - Endocrinol. Metab. 2007, 293:E1118-E1128.
178. Ye Z.W., Wu X.M., Jiang J.G. Expression changes of angiotensin II pathways and bioactive mediators during human preadipocytes-visceral differentiation. Metab. Clin. Exp. 2009, 58:1288-1296.
179. Yiannikouris F., Karounos M., Charnigo R., English V.L., Rateri D.L., Daugherty A., Cassis L.A. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 302:R244-R251.
180. Yim J.-E., Heshka S., Albu J.B., Heymsfield S., Gallagher D. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J. Appl. Physiol. 2008, 104:700-707.
181. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A.J., Tomiyama Y., et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
182. Yvan-Charvet L., Bobard A., Bossard P., Massiera F., Rousset X., Ailhaud G., Teboul M., Ferre P., Dagher G., Quignard-Boulange A. In vivo evidence for a role of adipose tissue SR-BI in the nutritional and hormonal regulation of adiposity and cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1340-1345.
183. Yvan-Charvet L., Even P., Bloch-Faure M., Guerre-Millo M., Moustaid-Moussa N., Ferre P., Quignard-Boulange A. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 2005, 54:991-999.
184. Yvan-Charvet L., Massiéra F., Lamandé N., Ailhaud G., Teboul M., Moustaid-Moussa N., Gasc J.-M., Quignard-Boulangé A. Deficiency of Angiotensin Type 2 Receptor Rescues Obesity But Not Hypertension Induced by Overexpression of Angiotensinogen in Adipose Tissue. Endocrinology 2009, 150:1421-1428.
185. Zhang S., Zhang X., Yang L., Yan Z., Yan L., Tian J., Li X., Song L., Wang L., Yang X., et al. Increased Susceptibility to Metabolic Syndrome in Adult Offspring of Angiotensin Type 1 Receptor Autoantibody-Positive Rats. Antioxid Redox Signal 2012.
186. Zheng J.M., Yao G.H., Cheng Z., Wang R., Liu Z.H. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease. Diabtologia 2012, 55:801-811.
187. Zhu Q., Wang Z., Xia M., Li P.L., Van Tassell B.W., Abbate A., Dhaduk R., Li N. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011, 58:657-664.